insights_auto
Why is AGIO down 4,56%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
30,15 USD
arrow_downward
-4,56%(-1,44) 1D
29,55 USD
arrow_downward
-1,99% (-0,60)bedtimeAfter hours
Closed: 16-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
31,29 USD
High
31,70 USD
Low
30,10 USD
Mkt. cap
1,80 млд
Avg. vol.
1,24 млн
Volume
0,00
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
31,29 USD
High
31,70 USD
Low
30,10 USD
Mkt. cap
1,80 млд
Avg. vol.
1,24 млн
Volume
0,00
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
TradingView
·
2 саат мурун
Stock Market: Will S&P 500 Open Up or Down Today?
ChartMill
·
13 саат мурун
Today's Most-Active S&P 500 Stocks: Ford Leads Volume as SMCI and Micron Fall
The Motley Fool
·
13 саат мурун
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
Traders Union
·
9 саат мурун
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc